ergot derivatives lectue 4.pptx dddddddddddddddddd

abdinuh1997 9 views 9 slides Nov 01, 2025
Slide 1
Slide 1 of 9
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9

About This Presentation

medicine for midwife


Slide Content

Drugs used in labor and pph By nuh

Ergot alkaloids Ergot alkaloids are either natural or semi synthetic Preparations Ergometrine- 0.25mg/ 0.5mg ampoules & 0.5-1mg tablets Methergine - 0.2 mg ampoules & 0.5-1mg tablets Syntometrine Ergometrine - 0.5 mg+ syntocinon 5.0 units ampoules

Cont.. Ergometrine & Methergine can be used parenterally or orally. As the drug produces titanic uterine contractions, it should only be used after delivery of the anterior shoulder or following delivery of baby.  It should not be used in induction of labor or abortion.  Syntometrine should always be administered IM

Mode of Action Ergometrine acts directly on the myometrium. It stimulates uterine contractions & decreases bleeding

indications Therapeutic 1To stop the atonic uterine bleeding following delivery, abortion/ expulsion of hydatidiform mole Prophylactic  As a prophylaxis against excessive hemorrhage , it may be administered after the delivery of the anterior shoulder with crowing / following delivery of baby.

Contraindications 1. Suspected pleural pregnancy 2. Organic cardiac disease 3. Severe Pre-eclampsia & Eclampsia

Adverse effects 1. Rise of BP due to vasoconstriction action 2. Prolonged use in puerperium may interfere by decrease concentration of prolactin & gangrene of toes due to vasoconstriction .

Dosage and routes of administration For active management of 3rd stage of labour -0.2mg( iamp ) to be given IM. For control of atonic PPH -1amp slowly over 60 seconds, may be repeated after 2hrs. For excessive lochia and subinvolution-1 Tablet(0.125mg)TDS for 3 days.

Nursing consideration 1. Assess patient BP, pulse, respiration, signs of hemorrhage 2. Administer Orally/IM deep, have emergency cart readily available 3. Evaluate for decrease blood loss 4. Advised patient to report for increased blood loss, abdominal cramps, headache, sweating, nausea, vomiting/ dyspnea
Tags